| First Author | Prados B | Year | 2007 |
| Journal | Am J Pathol | Volume | 170 |
| Issue | 5 | Pages | 1659-68 |
| PubMed ID | 17456771 | Mgi Jnum | J:121082 |
| Mgi Id | MGI:3709220 | Doi | 10.2353/ajpath.2007.061264 |
| Citation | Prados B, et al. (2007) Expression of the murine pomt1 gene in both the developing brain and adult muscle tissues and its relationship with clinical aspects of walker-warburg syndrome. Am J Pathol 170(5):1659-68 |
| abstractText | Walker-Warburg syndrome (WWS) is the most severe of a group of congenital disorders that have in common defects in the O-glycosylation of alpha-dystroglycan. WWS is characterized by congenital muscular dystrophy coupled with severe ocular and brain malformations. Moreover, in at least one-fifth of the reported cases, mutations in the POMT1 gene are responsible for this disease. During embryonic development (E8.5 to E11.5), the mouse Pomt1 gene is expressed in the tissues most severely affected in WWS, the muscle, eye, and brain. In this study, we show that mPomt1 expression is maintained in the muscle and eye in later developmental stages and, notably, that its expression is particularly strong in regions of brain and cerebellum that, when affected, could generate the defects observed in patients with WWS. We show that the Pomt1 protein is localized to the sarcoplasmic reticulum of muscle tissue cells in adult mice, where alpha-dystroglycan is O-glycosylated. Furthermore, the Pomt1 protein is localized to the acrosome of maturing spermatids, where alpha-dystroglycan is not glycosylated, so that Pomt1 might have a different target for O-mannosylation in the testes. This expression pattern in the testes could also be related to the gonadal anomalies observed in some patients with WWS. |
